Athira Pharma Stock (NASDAQ: ATHA) stock price, news, charts, stock research, profile.
Open | $2.52 |
Close | $2.57 |
Volume / Avg. | 74.17K / 153.17K |
Day Range | 2.48 - 2.65 |
52 Wk Range | 1.33 - 4.30 |
Market Cap | $94.67M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 3.76% |
Days to Cover | 6.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Athira Pharma (NASDAQ:ATHA) through any online brokerage.
Other companies in Athira Pharma’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Nutriband (NASDAQ:NTRB).
There is no analysis for Athira Pharma.
Athira Pharma has a consensus price target of $13.00.
The stock price for Athira Pharma (NASDAQ: ATHA) is $2.47 last updated July 3, 2024 at 1:58 PM EDT.
There are no upcoming dividends for Athira Pharma.
Athira Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Athira Pharma.
Athira Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.